These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21466419)

  • 21. Pseudohyperkalaemia in leukaemic patients: the effect of test tube type and form of transport to the laboratory.
    Dastych M; Cermáková Z
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):110-3. PubMed ID: 24045303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens.
    Bini EJ; Kinkhabwala A; Goldfarb DS
    Am J Kidney Dis; 2006 Oct; 48(4):580-6. PubMed ID: 16997054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
    de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR; Rolfe M
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spurious hyperkalaemia: an insight.
    Zaki KS; Majid U; Islam N
    J Pak Med Assoc; 2011 Mar; 61(3):297-9. PubMed ID: 21465953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudohyperkalaemia or spurious hyperkalaemia.
    Crook MA
    Ann Clin Biochem; 2013 Mar; 50(Pt 2):180-1. PubMed ID: 23512173
    [No Abstract]   [Full Text] [Related]  

  • 27. A case of undiagnosed pseudohyperkalaemia following a splenectomy.
    Grech M
    Age Ageing; 2018 Sep; 47(5):758-759. PubMed ID: 29757348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudohyperkalaemia caused by recentrifugation of blood samples after storage in gel separator tubes.
    Hira K; Ohtani Y; Rahman M; Noguchi Y; Shimbo T; Fukui T
    Ann Clin Biochem; 2001 Jul; 38(Pt 4):386-90. PubMed ID: 11471881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spurious hyperkalaemia due to EDTA contamination: common and not always easy to identify.
    Cornes MP; Ford C; Gama R
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):601-3. PubMed ID: 18768536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leaky cell syndrome: a rare cause of pseudohyperkalaemia.
    Lukens MV; de Mare A; Kerbert-Dreteler MJ; van den Bergh FA
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):97-100. PubMed ID: 22042978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects.
    Bailie GR; Eisele G; Liu L; Roys E; Kiser M; Finkelstein F; Wolfe R; Port F; Burrows-Hudson S; Saran R
    Nephrol Dial Transplant; 2005 Jun; 20(6):1110-5. PubMed ID: 15769809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
    Bakris GL; Pitt B; Weir MR; Freeman MW; Mayo MR; Garza D; Stasiv Y; Zawadzki R; Berman L; Bushinsky DA;
    JAMA; 2015 Jul; 314(2):151-61. PubMed ID: 26172895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of impaired potassium handling with dual renin-angiotensin-aldosterone blockade in chronic kidney disease.
    Preston RA; Afshartous D; Garg D; Medrano S; Alonso AB; Rodriguez R
    Hypertension; 2009 May; 53(5):754-60. PubMed ID: 19307466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of hyperkalemia in hospitalized patients.
    Fordjour KN; Walton T; Doran JJ
    Am J Med Sci; 2014 Feb; 347(2):93-100. PubMed ID: 23255245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases.
    Bianchi S; Bigazzi R; Campese VM
    Am J Kidney Dis; 2010 Apr; 55(4):671-81. PubMed ID: 20097461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence of chronic kidney disease (CKD) and significant contributors to CKD in HIV-infected patients].
    Nakamura Y; Shibuya A; Suzuki H; Ando M
    Nihon Jinzo Gakkai Shi; 2008; 50(4):499-505. PubMed ID: 18546881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudohyperkalaemia at commercial laboratories in Japan: a questionnaire survey.
    Hira K; Aoki N; Fukui T
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):155-6. PubMed ID: 15025808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.
    Bianchi S; Bigazzi R; Caiazza A; Campese VM
    Am J Kidney Dis; 2003 Mar; 41(3):565-70. PubMed ID: 12612979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.